Second-Line Chemotherapy for Metastatic Urothelial Carcinoma: Importance of Lymph Node-Only Metastasis as a Prognostic Factor and Construction of a Prognostic Model-Reference-Cited by-同舟云学术

Second-Line Chemotherapy for Metastatic Urothelial Carcinoma: Importance of Lymph Node-Only Metastasis as a Prognostic Factor and Construction of a Prognostic Model

Published:2016-06 Issue:3 Volume:14 Page:255-260
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Salah Samer,Lee Jae-Lyun,Rozzi Antonio^ORCID,Kitamura Hiroshi,Matsumoto Kazumasa,Srinivas Sandy,Morales-Barrera Rafael,Carles Joan,Al-Wardat Rami,Al-Rabi Kamal,Maakoseh Mohammad

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference23 articles.

1. First- and second-line therapy for metastatic urothelial carcinoma of the bladder;Yafi;Curr Oncol,2011

2. Metastatic bladder cancer: a review of current management;Fletcher;ISRN Urol,2011

3. Second-line systemic therapy for metastatic urothelial carcinoma of the bladder;Ortmann;Future Oncol,2013

4. Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract;Bellmunt;J Clin Oncol,2009

5. Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99];Albers;Ann Oncol,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Podcast on Practical Considerations in Patients with Advanced Urothelial Cancer Receiving First-Line Cisplatin- or Carboplatin-Based Chemotherapy Followed by Avelumab Maintenance in a Changing Therapeutic Landscape;Advances in Therapy;2024-07-18

2. Mortality prediction models after radical cystectomy for bladder tumour: A systematic review and critical appraisal;European Journal of Clinical Investigation;2022-06-13

3. Determinants of prognosis in metastatic urothelial carcinoma: a review of the literature;Journal of Cancer Metastasis and Treatment;2022

4. Survival Benefit for Patients With Metastatic Urothelial Carcinoma Receiving Continuous Maintenance Chemotherapy;In Vivo;2019

5. Second-line Chemotherapy in Older Patients With Metastatic Urothelial Carcinoma: Pooled Analysis of 10 Second-line Studies;Clinical Genitourinary Cancer;2017-08